Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma
Ocular Oncology and Pathology · 27.03.2026 · 1-8
DOI: 10.1159/000551167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 27.03.2026. Verfasst von Gillian A Folk und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California San Diego, La Jolla, CA, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Iris and ciliary body melanomas are rare but potentially life-threatening tumors that are difficult to distinguish from benign nevi. Earlier diagnosis improves outcomes, but reliable clinical indicators are limited. Glaucoma has been observed in conjunction with iris or ciliary body melanoma, but its prevalence and clinical significance at a population level are not well established. Our objective was to determine the prevalence of glaucoma in iris and ciliary body melanoma compared with nevus and to assess whether unilateral glaucoma may serve as a diagnostic indicator of melanoma.
Methods
This retrospective cohort study used the IBM MarketScan Research Database, which contains de-identified longitudinal healthcare claims data from commercially insured patients in the USA. Patients with iris or ciliary body melanoma or nevus were identified by International Classification of Diseases, Tenth Revision (ICD-10) diagnostic codes. Outcomes included the prevalence of glaucoma prior to treatment in melanoma versus nevus, age-stratified prevalence of glaucoma, and rates of glaucoma surgery. Odds ratios (ORs) with 95% CIs were calculated to compare groups.
Results
A total of 17,978 patients were included (112 with melanoma, 17,866 with nevus). Glaucoma prevalence prior to treatment was significantly higher in the melanoma cohort than nevus cohort (11.6% vs. 1.3%; OR: 10.1; 95% CI: 5.1–18.4; p < 0.001). This pattern persisted across all age groups, with the greatest relative difference observed in patients aged 20–39 years (10.9% vs. 0.7%; OR: 14.2; 95% CI: 1.5–63.0; p = 0.01). Among patients with glaucoma, surgery was required more frequently in the melanoma cohort (18.9%) than nevus cohort (15.0%).
Conclusion
Unilateral glaucoma is significantly more common in eyes with iris and ciliary body melanoma than in those with iris and ciliary body nevus in this claims-based cohort, and melanoma patients are more likely to require surgical management. Unilateral glaucoma may serve as an important early clinical indicator of melanoma, although further clinical correlation is necessary. Incorporating glaucoma status into diagnostic criteria could improve recognition, prompt referral and biopsy, and reduce delays in treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of California San Diego, La Jolla, CA, USA.
- Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.
Zitieren
APA
Folk, G. A., Ramesh, N., & Scott, N. L. (2026). Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma. Ocular Oncology and Pathology, 1-8. https://doi.org/10.1159/000551167
Vancouver
Folk GA, Ramesh N, Scott NL. Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma. Ocular Oncology and Pathology. 2026:1-8. doi:10.1159/000551167
BibTeX
@article{Folk2026,
author = {Folk, Gillian A and Ramesh, Naren and Scott, Nathan L},
title = {Unilateral Glaucoma as a Clinical Indicator of Iris and Ciliary Body Melanoma},
journal = {Ocular Oncology and Pathology},
year = {2026},
pages = {1--8},
doi = {10.1159/000551167}
}
EUVIMED